New Covid-19 Variant BA.3.2 Is Spreading and May Evade Immunity, CDC Warns

Published: Wednesday, March 25, 2026 at 5:45 pm

New COVID-19 Variant BA.3.2 Emerges, Raising Concerns

The Centers for Disease Control and Prevention (CDC) is closely monitoring the spread of a new COVID-19 variant, BA.3.2, an Omicron descendant, due to its potential to evade immunity from prior infection or vaccination. First detected in the United States last summer, the variant has since been identified in hospital patients across multiple states, including a young child. While all reported patients have survived, the CDC is concerned about BA.3.2's ability to potentially bypass existing immune defenses.

Currently, BA.3.2 accounts for a small percentage of sequenced COVID-19 cases. However, its presence has been detected in wastewater samples across numerous states, suggesting a potentially wider spread than current genomic data indicates. The CDC notes it is too early to determine if BA.3.2 will increase the severity of the illness or strain healthcare systems. Fortunately, there has been no notable rise in COVID-related deaths associated with the new variant.

The CDC's analysis indicates that BA.3.2 is primarily affecting the elderly and immunocompromised individuals. Two of the first three hospital patients detected with BA.3.2 were older adults with pre-existing health conditions.

Globally, the variant is spreading, with initial detection in South Africa in late 2024. It has since been identified in numerous countries, including those in Europe, where it accounts for a significant portion of new cases. Research suggests BA.3.2 may be more adept at evading antibodies produced by the current mRNA COVID-19 vaccines. The CDC acknowledges that the true extent of BA.3.2's spread may be underestimated due to limited genomic surveillance capabilities in some countries. The variant likely entered the U.S. through multiple independent introductions.

BNN's Perspective:

The emergence of new variants like BA.3.2 underscores the ongoing need for vigilance and public health measures. While the current data suggests the variant's impact is primarily on vulnerable populations, continued monitoring and research are crucial to understanding its full potential. Vaccination and adherence to public health guidelines remain important tools in mitigating the spread and impact of COVID-19.

Keywords: COVID-19, BA.3.2, variant, CDC, Omicron, immunity, vaccine, spread, elderly, immunocompromised, health, surveillance, mutations, Europe, South Africa

Full Story